Goodbody Health Stock Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.49M 3.41M | Sales 2021 | 17.06M 21.34M 29.14M | Capitalization | 13.76M 17.21M 23.5M |
---|---|---|---|---|---|
Net income 2020 | -4M -5M -6.83M | Net income 2021 | -2M -2.5M -3.42M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.72M 2.35M | Net cash position 2021 | 5.73M 7.17M 9.79M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
+37.37% | 6.02B | |
-15.69% | 4.49B | |
-12.46% | 3.06B | |
-0.12% | 3.04B | |
+0.47% | 2.61B | |
+36.06% | 1.81B | |
+0.84% | 1.66B | |
-10.60% | 1.63B | |
-12.03% | 1.55B |